For anyone in Wirts trying to locate CJC-1295, the foundational reality is that this compound is distributed via specialist online vendors. The upside of this online-only market is that serious vendors compete aggressively on their analytical documentation, giving researchers access to better quality signals than any local market ever offers. What genuinely separates top CJC-1295 vendors is comprehensive lot-matched testing data: HPLC for purity, mass spec for molecular identity verification, and endotoxin testing for contamination assurance. This guide gives Wirts researchers the practical tools to evaluate CJC-1295 vendors systematically and source high-purity CJC-1295 with confidence.
How CJC-1295 Works — Mechanisms & Research
The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Wirts researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.
CJC-1295 Purchasing Guide
Quality CJC-1295 sourcing begins with a useful first test: does this vendor share complete COA data without being asked? Suppliers that publish proactively are demonstrating research-grade standards. Endotoxin testing in the COA is essential for any injectable research use — endotoxins from microbial contamination can trigger severe inflammatory responses even at minute levels. The combination of community reputation data and your own COA analysis is the gold standard for CJC-1295 sourcing — community feedback surfaces systemic problems invisible in one transaction, and vice versa. For Wirts researchers making a first CJC-1295 purchase: verify the vendor against this framework, order conservatively at first, and check that batch numbers on your vial match the COA before use.
Order CJC-1295 — ships to Wirts
COA-verified · International tracking · Research grade
CJC-1295 operates outside approved pharmaceutical regulation — researchers should understand that the safety data available for CJC-1295 is based on academic studies rather than pharmaceutical approval data. Temperature excursions — even short periods above −20°C — can partially degrade CJC-1295 without any obvious sign; always verify cold chain was maintained during shipping. Bacterial endotoxin contamination is the most serious safety risk unique to this class of compound — verify endotoxin testing is documented in your batch COA before any injectable research application. PubMed are the primary literature resources for CJC-1295 research; prioritise peer-reviewed studies with characterised source material over unreviewed preprints or forum reports.
Frequently Asked Questions
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
